tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Imugene Initiates Phase II Trial for PD1-Vaxx in Colorectal Cancer
Company AnnouncementsImugene Initiates Phase II Trial for PD1-Vaxx in Colorectal Cancer
3d ago
Imugene’s Resolutions Passed at Extraordinary General Meeting
PremiumCompany Announcements
Imugene’s Resolutions Passed at Extraordinary General Meeting
4d ago
Imugene Advances Cancer Therapy Development with Promising Results
PremiumCompany Announcements
Imugene Advances Cancer Therapy Development with Promising Results
4d ago
Imugene Secures US Patent for Oncolytic Virotherapy, Strengthening Global IP Position
PremiumCompany Announcements
Imugene Secures US Patent for Oncolytic Virotherapy, Strengthening Global IP Position
12d ago
Imugene Limited Announces Cessation of Securities
PremiumCompany Announcements
Imugene Limited Announces Cessation of Securities
24d ago
Imugene Launches Phase II Trial for PD1-Vaxx in Colorectal Cancer
PremiumCompany AnnouncementsImugene Launches Phase II Trial for PD1-Vaxx in Colorectal Cancer
28d ago
Imugene Appoints Dr. John Byon as Chief Medical Officer to Advance Cancer Immunotherapy
Premium
Company Announcements
Imugene Appoints Dr. John Byon as Chief Medical Officer to Advance Cancer Immunotherapy
1M ago
Imugene Limited Announces Security Consolidation to Streamline Capital Structure
Premium
Company Announcements
Imugene Limited Announces Security Consolidation to Streamline Capital Structure
1M ago
Imugene Announces Share Consolidation and Seeks Approval for New Share Issuance
PremiumCompany Announcements
Imugene Announces Share Consolidation and Seeks Approval for New Share Issuance
1M ago
Imugene Issues Addendum to Extraordinary General Meeting Notice
PremiumCompany Announcements
Imugene Issues Addendum to Extraordinary General Meeting Notice
1M ago
Imugene Limited Announces Extraordinary General Meeting for June 2025
PremiumCompany Announcements
Imugene Limited Announces Extraordinary General Meeting for June 2025
1M ago
Imugene Limited Issues New Equity Securities as Part of Employee Incentive Scheme
PremiumCompany Announcements
Imugene Limited Issues New Equity Securities as Part of Employee Incentive Scheme
1M ago
Imugene Limited Announces Cessation of Securities
PremiumCompany AnnouncementsImugene Limited Announces Cessation of Securities
1M ago
Imugene Announces Proposed Share Consolidation to Enhance Market Position
Premium
Company Announcements
Imugene Announces Proposed Share Consolidation to Enhance Market Position
2M ago
Imugene Addresses Shareholder Concerns Amidst Market Challenges
Premium
Company Announcements
Imugene Addresses Shareholder Concerns Amidst Market Challenges
2M ago
Imugene Limited Announces Quotation of New Securities on ASX
PremiumCompany Announcements
Imugene Limited Announces Quotation of New Securities on ASX
3M ago
Imugene Limited Announces Cessation of Restricted Stock Units
PremiumCompany Announcements
Imugene Limited Announces Cessation of Restricted Stock Units
3M ago
Imugene Limited Issues New Restricted Stock Units to Employees
PremiumCompany Announcements
Imugene Limited Issues New Restricted Stock Units to Employees
3M ago
Imugene Limited Announces Investor Webinar to Discuss Business Updates
PremiumCompany Announcements
Imugene Limited Announces Investor Webinar to Discuss Business Updates
3M ago
Imugene Advances Phase 1 onCARlytics Trial with Dose Escalation Clearance
PremiumCompany AnnouncementsImugene Advances Phase 1 onCARlytics Trial with Dose Escalation Clearance
3M ago
Imugene’s Azer-cel Receives FDA Fast Track Designation for DLBCL
Premium
Company Announcements
Imugene’s Azer-cel Receives FDA Fast Track Designation for DLBCL
3M ago
Imugene Limited Announces Quotation of New Securities on ASX
Premium
Company Announcements
Imugene Limited Announces Quotation of New Securities on ASX
4M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >